RAPS Houston LNG presents the FDA ASCA Program Roadshow Panel Event, featuring Biotex, Inc at the TMC Innovation Factory. This panel brings together an FDA representative and Wade Munsch of Biotex, Inc — the only Houston-based lab currently accredited under the Accreditation Scheme for Conformity Assessment (ASCA) — to explore how ASCA can streamline premarket submissions and improve regulatory efficiency. Ideal for regulatory professionals, quality engineers, lab managers, and life science innovators across the region.
Houston's medical device ecosystem is expanding rapidly, and with that growth comes a pressing need for regional professionals to stay ahead of evolving regulatory pathways. RAPS Houston LNG is proud to present the FDA ASCA Program Roadshow Panel Event with Biotex, Inc. in partnership with TMC Innovation Factory.
This event is designed to educate regional manufacturers, laboratories, and regulatory professionals on the Accreditation Scheme for Conformity Assessment (ASCA) — an FDA program that allows accredited testing laboratories to verify that certain medical devices conform to recognized standards, helping streamline premarket submissions and reduce regulatory bottlenecks.
Attendees will hear directly from an FDA representative on the goals and mechanics of the ASCA program, followed by a presentation from Wade Munsch of Biotex, Inc, the only Houston-area laboratory to have attained ASCA accreditation. The evening will close with an interactive panel Q&A, giving attendees the opportunity to engage directly with both FDA and industry perspectives, followed by a networking reception.
This event is tailored for medical device regulatory affairs professionals, quality engineers, testing laboratory managers, and life science innovators seeking practical, actionable insight into how ASCA can support faster, more efficient paths to market.
TMC Innovation Factory
2450 Holcombe Blvd.
Suite X, Gate 2450
Houston, TX 77021
*Parking is free for the first two hours and then $11 for next 30 minutes.
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].

Senior Policy Analyst in the Conformity Assessment Program, FDA’s Center for Devices and Radiological Health


Senior Policy Analyst in the Conformity Assessment Program, FDA’s Center for Devices and Radiological Health
Shireen Fotelargias is a Senior Policy Analyst in the Conformity Assessment Program in the FDA’s Center for Devices and Radiological Health. She currently leads the internal education and training programs for the Accreditation Scheme for Conformity Assessment across the Center. Shireen also served as a Regulatory Health Program Manager for the FDA’s Center for Tobacco Products where she was a member of the review team that evaluated and implemented administrative and regulatory action in relation to scientific submissions for tobacco products. Before joining FDA, she was a Biosafety Specialist for the University of Maryland where she performed reviews of applications for authorization to conduct work with recombinant DNA, infectious agents, gene therapy and human materials. She received her B.S. in Biological Sciences from North Carolina State University and earned her M.S. in Biotechnology with a specialization in Biosecurity and Biodefense from University of Maryland.
Director of Quality Assurance & Regulatory Affairs, Biotex
Wade is the Director of Quality Assurance and Regulatory Affairs for Biotex, Inc. and the Laboratory Manager for Criterion, a Biotex, Inc. service. He has worked in compliance for over 16 years, including standards development and electrical safety evaluations with a specialty in medical devices. Throughout his career, Wade has worked for Certification Body (CB) and Nationally Recognized Testing Laboratory (NRTL) test laboratories and medical device manufacturers